EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease

Martin Hoenigl iD, Amir Arastehfar, Maiken Cavling Arendrup iD, Roger Brüggemann iD, Agostinho Carvalho iD, Tom Chiller, Sharon Chen, Matthias Egger iD, Simon Feys iD, Jean-Pierre Gangneux iD, Jeremy A W Gold iD, Andreas H Groll iD und 10 weitere

Clinical Microbiology Reviews · 13.06.2024 · 37 (2)

DOI: 10.1128/cmr.00074-23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 13.06.2024. Verfasst von Martin Hoenigl und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Infectious Diseases, ECMM Excellence Center for Medical Mycology, Medical University of Graz, Graz, Aust…. Hauptthemen laut MEDLINE: Antifungal Agents, Invasive Fungal Infections, Drug Resistance, Fungal. Die Arbeit wurde bisher 159-mal zitiert (Crossref) und nennt 502 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal infections are on the rise, driven by a growing population at risk and climate change. Currently available antifungals include only five classes, and their utility and efficacy in antifungal treatment are limited by one or more of innate or acquired resistance in some fungi, poor penetration into “sequestered” sites, and agent-specific side effect which require frequent patient reassessment and monitoring. Agents with novel mechanisms, favorable pharmacokinetic (PK) profiles including good oral bioavailability, and fungicidal mechanism(s) are urgently needed. Here, we provide a comprehensive review of novel antifungal agents, with both improved known mechanisms of actions and new antifungal classes, currently in clinical development for treating invasive yeast, mold (filamentous fungi), Pneumocystis jirovecii infections, and dimorphic fungi (endemic mycoses). We further focus on inhaled antifungals and the role of immunotherapy in tackling fungal infections, and the specific PK/pharmacodynamic profiles, tissue distributions as well as drug-drug interactions of novel antifungals. Finally, we review antifungal resistance mechanisms, the role of use of antifungal pesticides in agriculture as drivers of drug resistance, and detail detection methods for antifungal resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsInvasive Fungal InfectionsDrug Resistance, FungalHumansFungiAnimalsTreatment Outcome

Stichwörter der Autor:innen

fungal disease

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Infectious Diseases, ECMM Excellence Center for Medical Mycology, Medical University of Graz, Graz, Austria.
  • BiotechMed-Graz, Graz, Austria.
  • Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Unit of Mycology, Statens Serum Institut, Copenhagen, Denmark.
  • Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.

ORCID-Profile: Martin Hoenigl, Maiken Cavling Arendrup, Roger Brüggemann, Agostinho Carvalho, Matthias Egger, Simon Feys, Jean-Pierre Gangneux, Jeremy A W Gold, Andreas H Groll, Jannes Heylen, Jeffrey D Jenks, Robert Krause, Katrien Lagrou, Frédéric Lamoth, Sarah Sedik, Nathan P Wiederhold, George R Thompson

Zitieren

APA

Hoenigl, M., Arastehfar, A., Arendrup, M. C., Brüggemann, R., Carvalho, A., Chiller, T., Chen, S., Egger, M., Feys, S., Gangneux, J. P., Gold, J. A. W., Groll, A. H., Heylen, J., Jenks, J. D., Krause, R., Lagrou, K., Lamoth, F., Prattes, J., Sedik, S., …, & Thompson, G. R. (2024). Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical Microbiology Reviews, 37(2). https://doi.org/10.1128/cmr.00074-23

Vancouver

Hoenigl M, Arastehfar A, Arendrup MC, Brüggemann R, Carvalho A, Chiller T, et al. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clinical Microbiology Reviews. 2024;37(2). doi:10.1128/cmr.00074-23

BibTeX
@article{Hoenigl2024,
  author = {Hoenigl, Martin and Arastehfar, Amir and Arendrup, Maiken Cavling and Brüggemann, Roger and Carvalho, Agostinho and Chiller, Tom and Chen, Sharon and Egger, Matthias and Feys, Simon and Gangneux, Jean-Pierre and Gold, Jeremy A W and Groll, Andreas H and Heylen, Jannes and Jenks, Jeffrey D and Krause, Robert and Lagrou, Katrien and Lamoth, Frédéric and Prattes, Juergen and Sedik, Sarah and Wauters, Joost and Wiederhold, Nathan P and Thompson, George R},
  title = {Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease},
  journal = {Clinical Microbiology Reviews},
  year = {2024},
  volume = {37},
  number = {2},
  doi = {10.1128/cmr.00074-23}
}
Kostenlos starten →